WS #13445

From 498 msgs · 5 key-dev
Holding: newest synthesis is 107d 23h old

Novo Nordisk raised guidance but analysts unimpressed, with oral Wegovy and CagriSema results mixed, intensifying competition with Eli Lilly.

Novo Nordisk guidance and competition

Novo Nordisk raised guidance but analysts unimpressed, with oral Wegovy and CagriSema results mixed, intensifying competition with Eli Lilly.

Full world state #13445 →